chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer-BioNTech COVID-19 Vaccine EUA: one day after vaccination patient presented to urgent care reporting low back pain, difficulty breathing, cough, wheezing, and sleeping poorly. Patient tried rest, fluids, and albuterol prior to coming to urgent care, Vital signs within normal ranges except elevated heart rate and temperature. Provider documented patient was not hypoxic or in respiratory distress. Administered albuterol via nebulizer with improvement. Prescribed additional albuterol via nebulizer and inhaler, prescribed beclomethasone inhaler, and patient discharged to home with instructions for isolation and follow-up.
Vaccine was given at 840am on 4/14/2021.  Felt fine during the day.  Slept for a few hours. At 1a woke up to fever, chills, headache, joint soreness, sweating, then freezing.  I took tylenol throughout the following day but it barely made it the symptoms go away.  Symptoms continued until 9pm 4/15/2021.  4/16/2021 - continued muscle soreness and headache but fever has subsided.
The night following the vaccine, I woke up with above a 104 degree fever, soaking wet with sweat, chills, shaking and literally crawled to my living room for an extra blanket, even though it was warm.  Each hour the temperature went down and by around 8pm was starting to feel normal again.  I worked the next day, though exhausted.  Long term side affects have been weird spot bruising on both legs, but especially my left (sometimes big and for no reason).  I still have brain fog and fatigue.  I don't feel the same after the vaccine.  I can't put my finger on it, but I'm off.  The bruising is starting to concern me.  As of right now, my left knew has a huge bruise on the knee cap and I don't know why.  I drink wine, but not to that excess.  The bruise covers my entire knee cap and it's the not first time.  It's just strange.  I sometimes feel off and can't pin point why.
sharp muscle and joint pain; sharp muscle and joint pain; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.   The patient experienced sharp muscle and joint pain after her first and second shot of the vaccine.  The patient experienced sharp muscle and joint pain (myalgia) (non-serious) on an unspecified date with outcome of unknown, sharp muscle and joint pain (arthralgia) (non-serious) on an unspecified date with outcome of unknown.     Follow-up attempts are completed. No further information is expected.
Elevated temperature on and off for 2 days; screaming; decreased movement of legs with screaming on touch or PROM; interrupted sleep with decreased appetite; "not himself".
Night of 6/1 patient had left sided facial weekness, fever 101F. Patient was referred to ER 6/3 where Bell's Palsy Diagnosis was given.  Augmentin 3.5ml BID was started by PCP 6/3, Prednisolone 15mg/5ml - 4ml QD X10 days then taper was started on 6/3 in ER, Acyclovir 200mg/5ml - 5ml 4Xa day X12 days - started 6/6.
Pt was found in the bed red in the face and did not seem herself. She seemed to be short of breath and unable to swallow. Was brought to ER where blood sugar and blood gases were found to be normal and was warm to touch. Temperature was 98.3 by ear. Was sent to Morgantown for a  EEG on 08/31/2001.
pt recv vax w/pain, erythema @ site; fever to 102+ dx severe cellulitis;
weakened immune system; Shingles; Nerve pain; yeast infection; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain), FUNGAL INFECTION (yeast infection), IMMUNE SYSTEM DISORDER (weakened immune system) and HERPES ZOSTER (Shingles) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 028A21A) for COVID-19 vaccination.     The patient's past medical history included Accident automobile (on muscle relaxer). Concurrent medical conditions included Back muscle spasms (Car injury caused back spasm (prior to vaccine)) and Back pain (Car injury caused Back pain (prior to vaccine)). Concomitant products included VITAMINS NOS for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced FUNGAL INFECTION (yeast infection). In September 2021, the patient experienced NEURALGIA (Nerve pain) and HERPES ZOSTER (Shingles). On an unknown date, the patient experienced IMMUNE SYSTEM DISORDER (weakened immune system). The patient was treated with GABAPENTIN for Nerve pain, at a dose of rarely takes. At the time of the report, NEURALGIA (Nerve pain) had not resolved, FUNGAL INFECTION (yeast infection) and IMMUNE SYSTEM DISORDER (weakened immune system) outcome was unknown and HERPES ZOSTER (Shingles) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Hashimoto's bloodwork-normal. On an unknown date, Thyroid function test: normal (normal) normal.         Concomitant medications include: Muscle relaxer for back spasm and back pain, and Supplements Treatment medications include: OTC medication & One dose antibiotic for Yeast Infection, Antiviral Pill for Shingles.  The patient experienced yeast infection about  5-6 occurring almost monthly.On 6jan2022, the shingles have gotten better and almost gone but the nerve pain remains. Patient's doctor thinks the vaccine weakened the immune system. Patient planned for rheumatologist in feb2022.   This case was linked to MOD-2022-441583 (Patient Link).
Tiny blisters (burning, itching) on R ankle, thumb, L. forearm. Next day on R palm, fingers, L fingers, both elbows.  1 week later severe itching both eyes/eyelids, crusty eyes.
when I took that shot, I couldn't move my arm for three days; I noticed under my breast I have all these brown spot; My arm still kind of hurts me; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8732, Expiration Date: 31Jul2021, age at vaccination: 70 years), via an unspecified route of administration, administered in Arm left on 28Mar2021, at 11:00 as dose 1, single for covid-19 immunization. Medical history included blood pressure high. Concomitant medication included valsartan at 155/2.5 taken for blood pressure high. Prior vaccination (within four weeks) were none. The patient reported, she took her last Pfizer shot in May but her arm still kind of hurts me and then yesterday she noticed under her breast she had all these brown spots and was wondering if they had anything to do with the vaccine. After the first dose she couldn't move her arm for three days. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration Date: 31Jul2021, age at vaccination: 70 years), via an unspecified route of administration, administered in Arm left on 18Apr2021, at 11:00 as dose 2, single for covid-19 immunization. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Patient came in seeking what she wrote was her first dose of Pfizer. She filled out the paperwork and was given a dose of Pfizer vaccine, however, at checkout she indicated that this was in fact her booster dose. She had previously received CoronaVac , both first and second dose, in her home. The last dose was given more than 6 months ago (1st dose - 3/15/2021, 2nd dose - 4/16/2021). She said she decided to get Pfizer because healthcare individuals were giving Pfizer as a booster dose to those who had CoronaVac as their primary series. I have reached out to the Medical and Safety team.
On 1/7/21, seven days after receiving the first vaccine, I noticed a swollen and painful lymph node in my neck on the right side.  The lymph node was about the size of a large gumball.  The next day I started having pain in the lymph nodes of my arm pit on the right side.  The symptoms are still present six days later and I now have some swollen and tender lymph nodes in the antecubital area of the same arm.  I am scheduled to get my second dose on 1/21/21.  I have not had any other side affects that I know of other than feeling a little tired and mild headache on and off but that didn't seem unusual for me.  The lymph node in my neck seems to be getting a little smaller as of today 1/13/21.
Starting noticing at 4:00 PM noticing pain in the shoulder.  The pain in the shoulder got worse to where he had tightness in his chest, but was shaking uncontrollably shivering sensation but was not cold that continued for several hours.   Today is still having the pain in his shoulder, and while laying down has the neck stiffness.  While sitting up has pain in the shoulder and is applying ice on it now.  He took some  Acetimenophen as he was told to wait 24 hours before taking anything.   Has chronic back pain for which he takes that as well, but now for the shoulder pain as well.
Completed primary series on 10/27/22. Received 1st dose of bivalent booster on 11/28/22.
Breakthrough COVID case: The evening of Tuesday, late afternoon to early evening, I stared to feel like I was coming down with a head cold. I was feeling, my eyes and in my nose, just didn't feel right. I was sneezing and the next day was extremely miserable. I could not stop sneezing and coughing a little bit. I heard from a relative that I had been with a few days before that he had tested positive for COVID. I actually had taken a COVID home test on Monday evening which was negative. So, on Wednesday evening, I took another test which was positive. I did contact my physician and he called in a prescription for PAXLOVID. A five day course of treatment which I began taking Wednesday night about 1030. He advised me to stay home and isolate until Monday morning. He also advised me to make sure I did a lot of walking in the house and checked on me for the first couple days to make sure I was making progress. I still experienced sneezing, coughing, just very congested, but it improved some on Thursday. And, then, continued to improve each day after that. I did, per his advice, discontinue the atorvastatin until I finished the medication. I did experience periodic headaches but not severe.
I95.9 HYPOTENSION 11/13/2021 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE
Stomach cramping and persistent headache started on Sunday 1/10/21. On Wednesday, 1/13/21 developed a silver dollar size circle on arm at injection site that was sore, extremely hot to touch, tight and slight itch. Spread to size of a bagel or larger next day. Went to urgent care at that point, was informed it was an injection reaction, placed on Omnicef and Prednisone in case of bacterial infection. Symptoms on arm persisted for 2 weeks.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: Unknown. A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (non-serious), CARDIOVASCULAR DISORDER (non-serious), outcome "unknown" and all described as "someone had cardiovascular issues right now and has myocarditis". Clinical comment: The caller said that Pfizer took a piece of the HIV virus and inserted it into a spike so basically Pfizer injected people with the HIV virus that's why people are getting sick easier. He said that someone had cardiovascular issues right now and has myocarditis along with millions of other people around the world after getting the vaccine. It was asked to confirm if "someone" reported in Verbatim refers to one patient or not, since patient gender provided as Male. As a response the "someone" reported in the verbatim refers to one patient which happens to be a male. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Injection site pain, fatigue, fever, chills and hot flashes, muscle aches, headache and loss of appetite on 02/13/2021. Mild injection site pain, mild fatigue on 2/14/2021. Symptoms resolved by 2/15/2021.
by Sun. 31Jul, I checked myself into a hospital and my blood pressure was 207/94. I was given medication for BP, but it is still very erratic.; Suddenly on 25Jul I began vomiting which lasted into that night; For the next 5 days I remained very dizzy; The day after that shot I had fever, chills and soreness.; The day after that shot I had fever, chills and soreness.; The day after that shot I had fever, chills and soreness.; This is a spontaneous report from a contactable consumer (patient). This is the first of two reports with events experienced under the second dose. A 73-year-old female patient not pregnant received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 18Feb2021 14:15 (Lot Number: EL9267) as single dose (at age of 73-year-old) for covid-19 immunisation. Medical history included allergies to sulfa and penicillin, sjogren's syndrome, hypo thyroid. Concomitant medication received within 2 weeks of vaccination included levothyroxine sodium (SYNTHROID). The patient previously took first dose of bnt162b2 (BNT162B2) for covid-19 immunisation on 21Jan2021 03:15 PM in Left arm, lot number: EL9263 (at age of 73-year-old) and experienced pain in extremity (first vaccine shot 21Jan2021, her arm was very sore for 3 days), she previously received amoxicillin, clavulanic acid (AUGMENTIN) and experienced drug hypersensitivity. Facility where the most recent COVID-19 vaccine was administered: Public Health Clinic. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient stated that her blood pressure had been 110/70 her whole life. Her first vaccine shot was on 21Jan2021, her arm was very sore for 3 days. Patient had her second shot on 18Feb2021. The day after that shot (19Feb2021) she had fever, chills and soreness. Suddenly on 25Jul2021 at 09:30 she began vomiting which lasted into that night. For the next 5 days she remained very dizzy, on 31Jul2021 patient checked herself into a hospital and her blood pressure was 207/94, she was given medication for blood pressure (BP), but it was still very erratic. The patient was hospitalized for blood pressure was 207/94, vomiting and dizziness for 2 days. Events blood pressure was 207/94, vomiting and dizziness resulted in Emergency room/ department or urgent care, hospitalization and they were treated with blood pressure and anti vomiting medications. Since the vaccination, the patient has been tested for COVID-19, on 31Jul2021 with Nasal Swab and result was negative. Patient had not recovered from blood pressure was 207/94 and dizziness, she recovered on unknown date from Vomiting, while outcome of the other mentioned events was unknown. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101025465 same patient/reporter, different vaccine dose/AE
Very sick; Nausea; Tired; Chills; Broke out with a reaction on my entire body. Redness; Broke out with a reaction on my entire body. Redness and Itchy; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and the patient had a foreign variant of the virus in Dec2020. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and atorvastatin calcium (LIPITOR), both taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, first 48, the patient experienced very sick, nausea, tired, chills etc. On an unknown date in Apr2021, 24 hours, the patient experienced that a reaction broke out on her entire body, redness and itchy. These symptoms were only after the second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sick, nausea, tired, chills etc., reaction on her entire body, redness and itchy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
no edverse effects; patient was administered improperly stored PROQUAD; This spontaneous report as received from a nurse practicioner (also reported as nurse prescriber) refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.     On 14-MAY-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (exact dose and route of administration were not reported, lot # R008206 with and expiration date of 16-SEP-2019) for prophylaxis. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion from 6 to 14 degrees Fahrenheit (also reported as 13 degrees Fahrenheit) for 7 hours and from 15 to 46 degrees Fahrenheit (also reported as 34 degrees Fahrenheit) for 1 hour, which was reported as multiple excursions. Data logger was not involved.
body aches; muscle pain; joint pain; fatigue; swelling at the injection site; redness at the injection site; tenderness to the touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE PAIN (tenderness to the touch at the injection site), PAIN (body aches) and MYALGIA (muscle pain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PAIN (tenderness to the touch at the injection site). On 22-Jan-2021, the patient experienced PAIN (body aches), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (fatigue). At the time of the report, INJECTION SITE SWELLING (swelling at the injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE PAIN (tenderness to the touch at the injection site) had resolved and PAIN (body aches), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Injection site (Pain, Swelling, and Erythema), arthralgia, myalgia and fatigue are consistent with the product safety profile.
PATIENT COMPLAINING OF SORENESS AND REDNESS AT INJECTION SITE WHICH EXPANDED TO COVER HIS DELTOID AND UPPER BICEP.
some shortness of breath; Chills; body aches (in the chest and the back of the neck; soreness at injection site; Chest ache; increase in shortness of breath (having difficulty standing up and moving around; increase in shortness of breath (having difficulty standing up and moving around; This is a spontaneous report from a contactable consumer (patient self-reported). A 23-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: ER8729 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Apr2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies and allergies to medications, food, or other products. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP6955 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 19Mar2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient did not receive any other vaccine in four weeks. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 10Apr2021, the patient experienced chills, body aches (in the chest and the back of the neck), soreness at injection site, some shortness of breath, chest ache, increase in shortness of breath (having difficulty standing up and moving around). The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received treatment for the adverse event. Outcome of the events was recovering.  Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts completed. No further information expected.